Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest

Related Posts

Operations Update

September 23, 2024

Danielle DiMartino Booth: US Economy at Precipice —...

March 28, 2025

Goldman Sachs Cuts Copper Price Forecast on Weak...

September 5, 2024

Finlay Minerals Announces Non-Brokered Private Placement of Flow-Through...

May 26, 2025

Further High-Grade Intercepts at Kamperman

March 24, 2025

Charbone Hydrogene signe une entente de conditions pour...

May 2, 2025

5 Top Weekly TSXV Stocks: Timberline Gains 120...

April 22, 2024

FinEx Metals Provides Exploration Update on Ruoppa Gold...

July 21, 2025

High Grade Cu-Au at Surface Delivers New Targets...

July 9, 2025

New Purpose ETFs Give Canadian Investors Access to...

February 21, 2025